Back
Pieris Pharmaceuticals Vs. Cassava Sciences Industry Stock Comparison
Sell
31
PIRS
Pieris Pharmaceuticals
Last Price:
16.50
Seasonality Move:
-22.78%
Buy
66
SAVA
Cassava Sciences
Last Price:
30.46
Seasonality Move:
-4%
Sell
31
Pieris Pharmaceuticals (PIRS)
is a Sell
Is Pieris Pharmaceuticals a Buy, Sell or Hold?
- The current Pieris Pharmaceuticals [PIRS] share price is $16.16. The Score for PIRS is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- PIRS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
66
Cassava Sciences (SAVA)
is a Buy
Is Cassava Sciences a Buy, Sell or Hold?
- The current Cassava Sciences [SAVA] share price is $30.32. The Score for SAVA is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
- SAVA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PIRS Stock Price Chart
What is Pieris Pharmaceuticals's stock price today?
-
The Pieris Pharmaceuticals share price today is $16.16
The current trend is moderately bearish and PIRS is experiencing selling pressure, which indicates risk of future bearish movement.
SAVA Stock Price Chart
What is Cassava Sciences's stock price today?
-
The Cassava Sciences share price today is $30.32
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SAVA is experiencing slight selling pressure.
PIRS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.26 | Buy |
| Relative Strength Index (14 RSI): | 45.91 | Sell |
| Chaikin Money Flow: | -3180 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (16.62 - 18) | Sell |
| Bollinger Bands (100): | (8.84 - 16.36) | Buy |
SAVA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.25 | Buy |
| Relative Strength Index (14 RSI): | 59.12 | Buy |
| Chaikin Money Flow: | -921557 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (27 - 30.36) | Buy |
| Bollinger Bands (100): | (15.3 - 27.78) | Buy |
PIRS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 16.91 | Sell |
| 20-day SMA: | 17.47 | Sell |
| 50-day SMA: | 15.03 | Buy |
| 200-day SMA: | 13.2 | Buy |
| 8-day EMA: | 16.78 | Sell |
| 20-day EMA: | 16.89 | Sell |
| 50-day EMA: | 15.48 | Buy |
| 200-day EMA: | 17.96 | Sell |
SAVA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28.45 | Buy |
| 20-day SMA: | 28.81 | Buy |
| 50-day SMA: | 23.41 | Buy |
| 200-day SMA: | 22.36 | Buy |
| 8-day EMA: | 29.1 | Buy |
| 20-day EMA: | 28.16 | Buy |
| 50-day EMA: | 25.26 | Buy |
| 200-day EMA: | 22.47 | Buy |
Pieris Pharmaceuticals Earnings Growth & PIRS Earnings Dates
- Analysts estimate an earnings increase this quarter of $8.75 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.15 per share, and a decrease next year of $0.09 per share.
Cassava Sciences Earnings Growth & SAVA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.45 per share, and an increase next year of $0.97 per share.
Pieris Pharmaceuticals Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Cassava Sciences Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||